Rodney E. Rohde, PhD, a clinical laboratory scientist, helps break down how carefully EUA releases need to be read in order for the public and for scientists from other fields to parse them for useful information.
The US Food and Drug Administration (FDA) has taken action to authorize a wide variety of diagnostics for SARS-CoV-2 under the "Emergency Use Authorization" policy.
The authorization lasts as long as the relevant public health problem, but is not a full FDA approval.
Rodney E. Rohde, a clinical laboratory specialist at Texas State University, helps break down how carefully these releases need to be read in order for scientists from other fields to parse them for useful information.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
2 Commerce Drive
Cranbury, NJ 08512